Instil Bio (TIL) Other Accumulated Expenses (2020 - 2024)
Instil Bio (TIL) posted quarterly Other Accumulated Expenses of $107000.0 for Q3 2024, down 66.98% year-over-year from $324000.0 in Q4 2023, and down 25.17% quarter-over-quarter from $143000.0 in Q2 2024.
Instil Bio (TIL) Other Accumulated Expenses (2020 - 2024) Analysis & Trends
Instil Bio's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $107000.0 for Q3 2024.
- In Q3 2024, Other Accumulated Expenses fell 66.98% year-over-year to $107000.0; the TTM figure through Sep 2024 stood at $107000.0 (down 66.98% YoY), while the FY2023 annual figure was $190000.0, down 67.91% from the prior year.
- Other Accumulated Expenses for Q3 2024 stood at $107000.0, down from $143000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $933000.0 in Q3 2022, with the low at $107000.0 in Q3 2024.
- The 5-year median for Other Accumulated Expenses is $302500.0 (2020), against an average of $381937.5.
- The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses surged 361.66% in 2022, then tumbled 73.1% in 2024.
- Instil Bio's Other Accumulated Expenses stood at $281000.0 in 2020, then jumped by 37.37% to $386000.0 in 2021, then surged by 53.37% to $592000.0 in 2022, then sank by 67.91% to $190000.0 in 2023, then sank by 43.68% to $107000.0 in 2024.
- Business Quant data shows TIL's Other Accumulated Expenses at $107000.0 in Q3 2024, $143000.0 in Q2 2024, and $145000.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 143,000.00 |
| Mar 31, 2024 | 145,000.00 |
| Dec 31, 2023 | 190,000.00 |
| Sep 30, 2023 | 324,000.00 |
| Jun 30, 2023 | 339,000.00 |
| Mar 31, 2023 | 539,000.00 |
| Dec 31, 2022 | 592,000.00 |
| Sep 30, 2022 | 933,000.00 |
| Jun 30, 2022 | 891,000.00 |
| Mar 31, 2022 | 643,000.00 |
| Dec 31, 2021 | 386,000.00 |
| Sep 30, 2021 | 234,000.00 |
| Jun 30, 2021 | 193,000.00 |
| Mar 31, 2021 | 171,000.00 |
| Dec 31, 2020 | 281,000.00 |